mobile communication chip layout Search Results


90
Partners HealthCare System Inc clonal hematopoiesis of indeterminate potential
Clonal Hematopoiesis Of Indeterminate Potential, supplied by Partners HealthCare System Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/clonal+hematopoiesis+of+indeterminate+potential/10__1161_slash_strokeaha__121__037388-49-4-54
Average 90 stars, based on 1 article reviews
clonal hematopoiesis of indeterminate potential - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CH Instruments parent–child communication scale
Overview of parent–child communication measures
Parent–Child Communication Scale, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/parent+child+communication+scale/pmc09879831-231-10-14
Average 90 stars, based on 1 article reviews
parent–child communication scale - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CH Instruments 10-digit community health identifier
Overview of parent–child communication measures
10 Digit Community Health Identifier, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/community+health+index+number++chi+/pmc04577610-112-10-14
Average 90 stars, based on 1 article reviews
10-digit community health identifier - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare j-chip
Overview of parent–child communication measures
J Chip, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/j+chip/pm31901067-139-14-12
Average 90 stars, based on 1 article reviews
j-chip - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
OriGene multicancer tissue cdna array
Figure 1 BVES expression is significantly downregulated, and it is mislocalized in human colon carcinoma. (A) A human BVES hydrolysis probe was used to perform qPCR on an Origene <t>cDNA</t> array (TissueScan Cancer Survey I). Ct values were normalized to β-actin and then presented as fold reduction from matched normal (N) (n = 3 per tissue type) and tumor (T) tissue (n = 9 per tissue type). ***P < 0.001, 2-tailed unpaired t test. (B) Analysis of the combined Moffit Cancer Center and Vanderbilt Medical Center colon tumor expression array data set (10, normal samples; 6, adenomas; 33, stage I; 76, stage 2; 82, stage 3; and 59, stage 4; for combined total of 250 CRC samples). For whisker plots, the bottom and top of the boxes are the 25th and 75th percentile, respectively (the lower and upper quartiles, respectively), and the band near the middle of the box is the 50th percentile (median). The whiskers extend to the most extreme data points, which are no more than 1.5 times the interquartile range from the box. *P = 0.04, ***P = 0.001, ****P = 0.0001. (C) Representative immunofluorescence images from normal colon or adenocarci- noma (original magnification, ×400) of H&E, BVES (green), ZO-1 (red), DAPI (blue), and merged images.
Multicancer Tissue Cdna Array, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/TissueScan%2C+Cancer+Survey+cDNA+Array+96+-+I/10__1172_slash_jci44228-378-7-15
Average 93 stars, based on 1 article reviews
multicancer tissue cdna array - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

86
Atheros Communications chip
Figure 1 BVES expression is significantly downregulated, and it is mislocalized in human colon carcinoma. (A) A human BVES hydrolysis probe was used to perform qPCR on an Origene <t>cDNA</t> array (TissueScan Cancer Survey I). Ct values were normalized to β-actin and then presented as fold reduction from matched normal (N) (n = 3 per tissue type) and tumor (T) tissue (n = 9 per tissue type). ***P < 0.001, 2-tailed unpaired t test. (B) Analysis of the combined Moffit Cancer Center and Vanderbilt Medical Center colon tumor expression array data set (10, normal samples; 6, adenomas; 33, stage I; 76, stage 2; 82, stage 3; and 59, stage 4; for combined total of 250 CRC samples). For whisker plots, the bottom and top of the boxes are the 25th and 75th percentile, respectively (the lower and upper quartiles, respectively), and the band near the middle of the box is the 50th percentile (median). The whiskers extend to the most extreme data points, which are no more than 1.5 times the interquartile range from the box. *P = 0.04, ***P = 0.001, ****P = 0.0001. (C) Representative immunofluorescence images from normal colon or adenocarci- noma (original magnification, ×400) of H&E, BVES (green), ZO-1 (red), DAPI (blue), and merged images.
Chip, supplied by Atheros Communications, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/us12653504-1087-1-12
Average 86 stars, based on 1 article reviews
chip - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

93
OriGene human tissuescan cancer survey cdna array 96
Figure 5. TACC3 is elevated in a variety of human cancer types. (a) Transcript expression of TACC3 in eight solid human cancers, including breast, colon, kidney, liver, lung, ovary, prostate and thyroid cancers, was determined using <t>TissueScan</t> Cancer Survey qPCR array analysis. (b) Representative immunohistochemical staining of TACC3 on breast (normal breast tissues (n = 10) and breast cancer tissues (n = 100)) and lung (normal lung tissues (n = 10) and lung cancer tissues (n = 110)) cancer tissue microarrays (left panel). Quantitative analysis of breast and lung cancer tissue microarrays showed that the expression of TACC3 is higher in cancer tissues than in normal tissues (right panel). (c) Kaplan–Meier survival curves of breast (left panel) and lung (right panel) cancer patients based on TACC3 expression. (d) Graphs showing an inverse correlation between TACC3 and ATM mRNA levels in breast (Pearson’s r = −0.51341; Po0.01) and lung (Pearson’s r = −0.72401; Po0.0005) cancers based on TissueScan Cancer Survey qPCR array analysis. (e) A graph showing a positive correlation between TACC3 and γH2AX staining intensity scores of breast cancer tissue microarrays (n = 75) (Pearson’s r = 0.70052; Po0.05).
Human Tissuescan Cancer Survey Cdna Array 96, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/TissueScan%2C+Cancer+Survey+cDNA+Array+96+-+I/pm24769898-150-4-11
Average 93 stars, based on 1 article reviews
human tissuescan cancer survey cdna array 96 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Atheros Communications atheros ar9331 chip
Figure 5. TACC3 is elevated in a variety of human cancer types. (a) Transcript expression of TACC3 in eight solid human cancers, including breast, colon, kidney, liver, lung, ovary, prostate and thyroid cancers, was determined using <t>TissueScan</t> Cancer Survey qPCR array analysis. (b) Representative immunohistochemical staining of TACC3 on breast (normal breast tissues (n = 10) and breast cancer tissues (n = 100)) and lung (normal lung tissues (n = 10) and lung cancer tissues (n = 110)) cancer tissue microarrays (left panel). Quantitative analysis of breast and lung cancer tissue microarrays showed that the expression of TACC3 is higher in cancer tissues than in normal tissues (right panel). (c) Kaplan–Meier survival curves of breast (left panel) and lung (right panel) cancer patients based on TACC3 expression. (d) Graphs showing an inverse correlation between TACC3 and ATM mRNA levels in breast (Pearson’s r = −0.51341; Po0.01) and lung (Pearson’s r = −0.72401; Po0.0005) cancers based on TissueScan Cancer Survey qPCR array analysis. (e) A graph showing a positive correlation between TACC3 and γH2AX staining intensity scores of breast cancer tissue microarrays (n = 75) (Pearson’s r = 0.70052; Po0.05).
Atheros Ar9331 Chip, supplied by Atheros Communications, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/atheros+ar9331/pmc11647870-323-6-7
Average 90 stars, based on 1 article reviews
atheros ar9331 chip - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CH Instruments pearson ́s chi-square test
Figure 5. TACC3 is elevated in a variety of human cancer types. (a) Transcript expression of TACC3 in eight solid human cancers, including breast, colon, kidney, liver, lung, ovary, prostate and thyroid cancers, was determined using <t>TissueScan</t> Cancer Survey qPCR array analysis. (b) Representative immunohistochemical staining of TACC3 on breast (normal breast tissues (n = 10) and breast cancer tissues (n = 100)) and lung (normal lung tissues (n = 10) and lung cancer tissues (n = 110)) cancer tissue microarrays (left panel). Quantitative analysis of breast and lung cancer tissue microarrays showed that the expression of TACC3 is higher in cancer tissues than in normal tissues (right panel). (c) Kaplan–Meier survival curves of breast (left panel) and lung (right panel) cancer patients based on TACC3 expression. (d) Graphs showing an inverse correlation between TACC3 and ATM mRNA levels in breast (Pearson’s r = −0.51341; Po0.01) and lung (Pearson’s r = −0.72401; Po0.0005) cancers based on TissueScan Cancer Survey qPCR array analysis. (e) A graph showing a positive correlation between TACC3 and γH2AX staining intensity scores of breast cancer tissue microarrays (n = 75) (Pearson’s r = 0.70052; Po0.05).
Pearson ́s Chi Square Test, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/pearson+chi+square+test/pmc08718903-105-30-32
Average 90 stars, based on 1 article reviews
pearson ́s chi-square test - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
CH Instruments chi-square
Figure 5. TACC3 is elevated in a variety of human cancer types. (a) Transcript expression of TACC3 in eight solid human cancers, including breast, colon, kidney, liver, lung, ovary, prostate and thyroid cancers, was determined using <t>TissueScan</t> Cancer Survey qPCR array analysis. (b) Representative immunohistochemical staining of TACC3 on breast (normal breast tissues (n = 10) and breast cancer tissues (n = 100)) and lung (normal lung tissues (n = 10) and lung cancer tissues (n = 110)) cancer tissue microarrays (left panel). Quantitative analysis of breast and lung cancer tissue microarrays showed that the expression of TACC3 is higher in cancer tissues than in normal tissues (right panel). (c) Kaplan–Meier survival curves of breast (left panel) and lung (right panel) cancer patients based on TACC3 expression. (d) Graphs showing an inverse correlation between TACC3 and ATM mRNA levels in breast (Pearson’s r = −0.51341; Po0.01) and lung (Pearson’s r = −0.72401; Po0.0005) cancers based on TissueScan Cancer Survey qPCR array analysis. (e) A graph showing a positive correlation between TACC3 and γH2AX staining intensity scores of breast cancer tissue microarrays (n = 75) (Pearson’s r = 0.70052; Po0.05).
Chi Square, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/chi+square/pmc03417711-95-8-9
Average 90 stars, based on 1 article reviews
chi-square - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

96
Cytiva Europe series s sensor chip cm5
Figure 5. TACC3 is elevated in a variety of human cancer types. (a) Transcript expression of TACC3 in eight solid human cancers, including breast, colon, kidney, liver, lung, ovary, prostate and thyroid cancers, was determined using <t>TissueScan</t> Cancer Survey qPCR array analysis. (b) Representative immunohistochemical staining of TACC3 on breast (normal breast tissues (n = 10) and breast cancer tissues (n = 100)) and lung (normal lung tissues (n = 10) and lung cancer tissues (n = 110)) cancer tissue microarrays (left panel). Quantitative analysis of breast and lung cancer tissue microarrays showed that the expression of TACC3 is higher in cancer tissues than in normal tissues (right panel). (c) Kaplan–Meier survival curves of breast (left panel) and lung (right panel) cancer patients based on TACC3 expression. (d) Graphs showing an inverse correlation between TACC3 and ATM mRNA levels in breast (Pearson’s r = −0.51341; Po0.01) and lung (Pearson’s r = −0.72401; Po0.0005) cancers based on TissueScan Cancer Survey qPCR array analysis. (e) A graph showing a positive correlation between TACC3 and γH2AX staining intensity scores of breast cancer tissue microarrays (n = 75) (Pearson’s r = 0.70052; Po0.05).
Series S Sensor Chip Cm5, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/Series+S+Sensor+Chip+CM5%2C+pack+of+1/pmc09136614-180-223-228
Average 96 stars, based on 1 article reviews
series s sensor chip cm5 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

86
Texas Instruments ghz radio communications chip
Figure 5. TACC3 is elevated in a variety of human cancer types. (a) Transcript expression of TACC3 in eight solid human cancers, including breast, colon, kidney, liver, lung, ovary, prostate and thyroid cancers, was determined using <t>TissueScan</t> Cancer Survey qPCR array analysis. (b) Representative immunohistochemical staining of TACC3 on breast (normal breast tissues (n = 10) and breast cancer tissues (n = 100)) and lung (normal lung tissues (n = 10) and lung cancer tissues (n = 110)) cancer tissue microarrays (left panel). Quantitative analysis of breast and lung cancer tissue microarrays showed that the expression of TACC3 is higher in cancer tissues than in normal tissues (right panel). (c) Kaplan–Meier survival curves of breast (left panel) and lung (right panel) cancer patients based on TACC3 expression. (d) Graphs showing an inverse correlation between TACC3 and ATM mRNA levels in breast (Pearson’s r = −0.51341; Po0.01) and lung (Pearson’s r = −0.72401; Po0.0005) cancers based on TissueScan Cancer Survey qPCR array analysis. (e) A graph showing a positive correlation between TACC3 and γH2AX staining intensity scores of breast cancer tissue microarrays (n = 75) (Pearson’s r = 0.70052; Po0.05).
Ghz Radio Communications Chip, supplied by Texas Instruments, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mobile+communication+chip+layout/chip+communications+ghz+radio/us12576258-1561-2-8
Average 86 stars, based on 1 article reviews
ghz radio communications chip - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Overview of parent–child communication measures

Journal: Clinical Child and Family Psychology Review

Article Title: A Systematic Review of Parent–Child Communication Measures: Instruments and Their Psychometric Properties

doi: 10.1007/s10567-022-00414-3

Figure Lengend Snippet: Overview of parent–child communication measures

Article Snippet: The Father-Adolescent/Mother-Adolescent Communication Scale (FACS/MACS; Shek et al., ), the Parent–Child Communication Scale (PCCS; Chi, ), the Perception of Parenting Communication Scale (COMPA; Portugal & Alberto, ), the Parent-Adolescent Communication Inventory (PACI; Schmidt et al., ), and the Family Communication Patterns Scale (FCP; McLeod et al., ) were all used in one study each.

Techniques: Expressing

Psychometric quality assessment of parent–child communication measures

Journal: Clinical Child and Family Psychology Review

Article Title: A Systematic Review of Parent–Child Communication Measures: Instruments and Their Psychometric Properties

doi: 10.1007/s10567-022-00414-3

Figure Lengend Snippet: Psychometric quality assessment of parent–child communication measures

Article Snippet: The Father-Adolescent/Mother-Adolescent Communication Scale (FACS/MACS; Shek et al., ), the Parent–Child Communication Scale (PCCS; Chi, ), the Perception of Parenting Communication Scale (COMPA; Portugal & Alberto, ), the Parent-Adolescent Communication Inventory (PACI; Schmidt et al., ), and the Family Communication Patterns Scale (FCP; McLeod et al., ) were all used in one study each.

Techniques:

Figure 1 BVES expression is significantly downregulated, and it is mislocalized in human colon carcinoma. (A) A human BVES hydrolysis probe was used to perform qPCR on an Origene cDNA array (TissueScan Cancer Survey I). Ct values were normalized to β-actin and then presented as fold reduction from matched normal (N) (n = 3 per tissue type) and tumor (T) tissue (n = 9 per tissue type). ***P < 0.001, 2-tailed unpaired t test. (B) Analysis of the combined Moffit Cancer Center and Vanderbilt Medical Center colon tumor expression array data set (10, normal samples; 6, adenomas; 33, stage I; 76, stage 2; 82, stage 3; and 59, stage 4; for combined total of 250 CRC samples). For whisker plots, the bottom and top of the boxes are the 25th and 75th percentile, respectively (the lower and upper quartiles, respectively), and the band near the middle of the box is the 50th percentile (median). The whiskers extend to the most extreme data points, which are no more than 1.5 times the interquartile range from the box. *P = 0.04, ***P = 0.001, ****P = 0.0001. (C) Representative immunofluorescence images from normal colon or adenocarci- noma (original magnification, ×400) of H&E, BVES (green), ZO-1 (red), DAPI (blue), and merged images.

Journal: Journal of Clinical Investigation

Article Title: BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma

doi: 10.1172/jci44228

Figure Lengend Snippet: Figure 1 BVES expression is significantly downregulated, and it is mislocalized in human colon carcinoma. (A) A human BVES hydrolysis probe was used to perform qPCR on an Origene cDNA array (TissueScan Cancer Survey I). Ct values were normalized to β-actin and then presented as fold reduction from matched normal (N) (n = 3 per tissue type) and tumor (T) tissue (n = 9 per tissue type). ***P < 0.001, 2-tailed unpaired t test. (B) Analysis of the combined Moffit Cancer Center and Vanderbilt Medical Center colon tumor expression array data set (10, normal samples; 6, adenomas; 33, stage I; 76, stage 2; 82, stage 3; and 59, stage 4; for combined total of 250 CRC samples). For whisker plots, the bottom and top of the boxes are the 25th and 75th percentile, respectively (the lower and upper quartiles, respectively), and the band near the middle of the box is the 50th percentile (median). The whiskers extend to the most extreme data points, which are no more than 1.5 times the interquartile range from the box. *P = 0.04, ***P = 0.001, ****P = 0.0001. (C) Representative immunofluorescence images from normal colon or adenocarci- noma (original magnification, ×400) of H&E, BVES (green), ZO-1 (red), DAPI (blue), and merged images.

Article Snippet: BVES TaqMan qRT-PCR was performed on a multicancer tissue cDNA array (TissueScan Cancer Survey I, OriGene) according to the manufacturers protocol.

Techniques: Expressing, Whisker Assay, Immunofluorescence

Figure 5. TACC3 is elevated in a variety of human cancer types. (a) Transcript expression of TACC3 in eight solid human cancers, including breast, colon, kidney, liver, lung, ovary, prostate and thyroid cancers, was determined using TissueScan Cancer Survey qPCR array analysis. (b) Representative immunohistochemical staining of TACC3 on breast (normal breast tissues (n = 10) and breast cancer tissues (n = 100)) and lung (normal lung tissues (n = 10) and lung cancer tissues (n = 110)) cancer tissue microarrays (left panel). Quantitative analysis of breast and lung cancer tissue microarrays showed that the expression of TACC3 is higher in cancer tissues than in normal tissues (right panel). (c) Kaplan–Meier survival curves of breast (left panel) and lung (right panel) cancer patients based on TACC3 expression. (d) Graphs showing an inverse correlation between TACC3 and ATM mRNA levels in breast (Pearson’s r = −0.51341; Po0.01) and lung (Pearson’s r = −0.72401; Po0.0005) cancers based on TissueScan Cancer Survey qPCR array analysis. (e) A graph showing a positive correlation between TACC3 and γH2AX staining intensity scores of breast cancer tissue microarrays (n = 75) (Pearson’s r = 0.70052; Po0.05).

Journal: Oncogene

Article Title: TACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition.

doi: 10.1038/onc.2014.105

Figure Lengend Snippet: Figure 5. TACC3 is elevated in a variety of human cancer types. (a) Transcript expression of TACC3 in eight solid human cancers, including breast, colon, kidney, liver, lung, ovary, prostate and thyroid cancers, was determined using TissueScan Cancer Survey qPCR array analysis. (b) Representative immunohistochemical staining of TACC3 on breast (normal breast tissues (n = 10) and breast cancer tissues (n = 100)) and lung (normal lung tissues (n = 10) and lung cancer tissues (n = 110)) cancer tissue microarrays (left panel). Quantitative analysis of breast and lung cancer tissue microarrays showed that the expression of TACC3 is higher in cancer tissues than in normal tissues (right panel). (c) Kaplan–Meier survival curves of breast (left panel) and lung (right panel) cancer patients based on TACC3 expression. (d) Graphs showing an inverse correlation between TACC3 and ATM mRNA levels in breast (Pearson’s r = −0.51341; Po0.01) and lung (Pearson’s r = −0.72401; Po0.0005) cancers based on TissueScan Cancer Survey qPCR array analysis. (e) A graph showing a positive correlation between TACC3 and γH2AX staining intensity scores of breast cancer tissue microarrays (n = 75) (Pearson’s r = 0.70052; Po0.05).

Article Snippet: TissueScan qPCR array The human TissueScan Cancer Survey cDNA array 96-I (OriGene Technologies Inc, Rockville, MD, USA) consisted of 96 tissues from eight solid tumors (breast, colon, kidney, liver, lung, ovary, prostate and thyroid). qPCR was performed in 96-well PCR array plates using the iCycler iQ5 realtime PCR detection system (Bio-Rad, Hercules, CA, USA) and an iQ SYBR Green supermix (Bio-Rad).

Techniques: Expressing, Immunohistochemical staining, Staining